2022 spells change for EU pharmaceutical legislation
European Pharmaceutical Review
JUNE 24, 2022
This suggests that any of the modelled changes to the regulation could lead to a decrease in the number of OMPs developed… Some of the assessed changes to the regulation could undermine the business model under which OMP?focused Maarten has significant competition law experience in a variety of sectors. About the author. References.
Let's personalize your content